Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.

Proceedings of the Association of American Physicians

Volumn 108, Issue 2, 1996, Pages 155-164

  Kassem, M ^a   Okazaki, R ^a   De Leon D ^a   Harris, S A ^a   Robinson, J A ^a   Spelsberg, T C ^a   Conover, C A ^a   Riggs, B L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BUCLADESINE; CYCLIC AMP; ESTRADIOL; ESTROGEN; FORSKOLIN; MESSENGER RNA; PROGESTERONE RECEPTOR; PROMEGESTONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4;

ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; CELL DIVISION; CELL LINE; CULTURE MEDIUM; DRUG POTENTIATION; GENETICS; HUMAN; METABOLISM; OSTEOBLAST; PHYSIOLOGY;

ANTIBODIES; BUCLADESINE; CELL DIVISION; CELL LINE; CULTURE MEDIA, CONDITIONED; CYCLIC AMP; ESTRADIOL; ESTROGENS; FORSKOLIN; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR II; OSTEOBLASTS; OSTEOGENESIS; PROMEGESTONE; RECEPTORS, PROGESTERONE; RNA, MESSENGER;

EID: 0030096921     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)